STSA - Satsuma Pharmaceuticals EPS misses by $0.19 March, 25 2021 05:14 PM Satsuma Pharmaceuticals Inc. Satsuma Pharmaceuticals (STSA): Q4 GAAP EPS of -$0.72 misses by $0.19.Cash, cash equivalents and marketable securities of $68.2M.Press Release For further details see: Satsuma Pharmaceuticals EPS misses by $0.19